Message from the Director
As NIDDK celebrates its 70th anniversary, we look back on decades of scientific advances and forward to what we will achieve in the decades to come. Discovery and innovation are at the core of our institute, the result of the dedication and talent of our staff and grantees. Our achievements together have led to better ways to prevent and treat conditions among the countrys greatest public health concerns, including diabetes, obesity, kidney diseases, and many others in our diverse mission. I invite you to read about some of these advances in the links below and to follow the development of our strategic plan, which will guide how NIDDK will maximize public investment in research and amplify efforts where needed the most.
This year weve faced remarkable challenges, as a global pandemic upended life as we know it. NIDDK staff, grantees, and trainees have risen to that charge at every step, joining the search for ways to combat COVID-19 or pioneering solutions to keep operations running smoothlydespite many uncertainties. With a strengthened spirit of community, we embark on the next 70 years with compassion and determination to preserve and advance public health.
- Griffin P. Rodgers, M.D., M.A.C.P.
Click anywhere on the NIDDK social media messages below to then like and share the posts on your Facebook and Twitter pages
Download our NIDDK 70th Anniversary Social Media Graphics (ZIP, 749.08 KB) and content to post on your Instagram , Facebook, and Twitter pages.
Over the past 70 years, NIDDK has made substantial scientific research advancements and our scientists have been honored with prestigious awards for their work to improve public health. Looking forward, we strive to discover better ways to help manage and treat diseases central to our missions. Learn more about NIDDK and its advances in the NIH almanac.
October 16, 1968 Dr. Nirenberg of the National Heart Institute shared the Nobel Prize in Physiology or Medicine with two other scientists. Dr. Nirenberg reported his celebrated partial cracking of the genetic code while an NIAMD scientist.
October 1972 Dr. Afinsen, chief of the Institutes Laboratory ofChemical Biology, shared the Nobel Prize in Chemistry with twoother American scientists for demonstrating one of the mostimportant simplifying concepts of molecular biology: that the threedimensionalconformation of a native protein is determined by thechemistry of its amino acid sequence. A significant part of theresearch cited by the award was performed while Anfinsen was withthe NIH.
November 1982 Dr. Neufeld, chief of the NIADDKs genetics andbiochemistry branch, received the Albert Lasker Clinical MedicalResearch Award. She was cited, along with Dr. Roscoe O. Brady ofthe then-named National Institute of Neurological andCommunicative Disorders and Stroke, for their contributions to theunderstanding and diagnosis of inherited diseases calledmucopolysaccharide storage disorders.
September 2010 Dr. Friedman, a NIDDK grantee and formergrantee Dr. Douglas Coleman won the Albert Lasker Basic MedicalResearch Award for discovering the hormone leptin, which plays akey role in regulating energy intake and energy expenditure.
September 21, 2012 Dr. Starzl, a longtime NIDDK grantee, receivedthe Lasker-DeBakey Clinical Medical Research Award, shared withanother scientist for his work developing liver transplantation, anintervention that has restored normal life to thousands of peoplewith end-stage liver disease.
September 2016 Dr. Semenza, a NIDDK grantee, shared the AlbertLasker Basic Medical Research Award with NIH grantee Dr. WilliamG. Kaelin Jr. and another scientist for their discovery of the pathwayby which cells from humans and most animals sense and adapt tochanges in oxygen availabilitya process essential for survival.
October 7, 2019 NIDDK grantee Dr. Semenza shared the Nobel Prizein Physiology or Medicine with NIH grantee Dr. William G. Kaelin Jr.and another scientist for their discoveries of how cells sense andadapt to oxygen availability.
Chronic liver disease can result from many causes, the two most common being viral hepatitisincluding hepatitis B, C, and Dand nonalcoholic fatty liver disease (NAFLD). NIDDK-supported research has yielded important knowledge that has improved the lives of people with many forms of chronic liver disease.
Over the past several decades, NIDDK has supported research to improve our understanding of Inflammatory Bowel Disease (IBD) through development of new approaches to study IBD and genetics, gut microbiome research, and personalized treatments for patients with IBD.
An estimated 37 million American adults have Chronic Kidney Disease (CKD), and kidney diseases are the ninth leading cause of death in the United States. NIDDKs continued development and testing of new detection strategies, therapies, and community education helps support the health and quality of life of people with CKD.
Nutrition plays a fundamental role in sustaining health and preventing disease. The NIDDK supports an extensive and collaborative portfolio in nutrition research, including clinical studies of diet and nutrition, microbiomes, and precision approaches to dietary recommendations.
Obesity has risen to epidemic levels in the United States and it is a major public health challenge. NIDDK-supported research has improved our understanding of body weight regulation and yielded new treatment approaches for people with obesity.
NIDDK-funded research has made important strides in developing new treatments for diseases like Sickle Cell Disease and understanding anemia. Recently, research into how cells detect oxygen and react to low oxygen levels was selected as the 2019 Nobel Prize in Physiology or Medicine.
NIDDK-supported research has led to critical knowledge in areas of intensive glucose control, preventing type 1 diabetes and improving longevity of people with the disease.
NIDDK research seeks to reduce the burden of this serious and all too common disease with findings shown to prevent, delay, and treat T2D in high-risk people or those living with the disease. NIDDK research also focuses its efforts in gestational diabetes studies and T2D in special populations.
The Healthy Moments celebration of NIDDKs 70th anniversary features five talks with NIHDirector, Dr. Francis Collins.
Episode 1: Creating Medical Devices to Improve Treatment of Type 1 Diabetes
Episode 2: Using Genetics to Improve Treatment of Type 2 Diabetes
Episode 3: Fighting Kidney Disease with Precision Medicine
Episode 4: Decoding the Burden of Inflammatory Bowel Disease
Episode 5: Making Obesity Treatment More Personal
Healthy Moments is a weekly broadcast that provides listeners reliable, science-based,healthy lifestyle tips, actionable suggestions, and other important health informationfeaturing Dr. Griffin Rodgers, Director of NIDDK. View more Healthy Moments episodes.
Originally posted here:
- Reducing barriers to mainstream gene therapy - BioPharma-Reporter.com - September 4th, 2020
- Mapping Genetic Diversity of Lung Tumors Over Time May Lead to More Effective Therapies - UCSF News Services - September 4th, 2020
- Multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer - PRNewswire - September 4th, 2020
- Global Prime Editing Market to Witness Heightened Growth During the Period 2020 2030 - The Daily Chronicle - September 4th, 2020
- Liquid biopsies to disrupt the oncology testing market - Medical Device Network - September 4th, 2020
- Global RNA-interference (RNAi) Market Growth, Trends and Forecasts to 2025: Focus on Key Players Alnylam Pharmaceuticals, Arrowhead, Quark... - September 4th, 2020
- Yale researchers find a cause and possible treatment for Fragile X - Yale News - September 4th, 2020
- 'Coming into their own': FDA approval of liquid biopsy tests puts early, less invasive cancer detection in broader reach - USA TODAY - September 4th, 2020
- Fusion Genes Associated With More Aggressive Papillary Thyroid Cancer in Pediatric Patients - Targeted Oncology - September 4th, 2020
- Existing Class of Drugs May Improve Neurological Function in Patients with Rare, Aggressive Genetic Disorder - Newswise - September 4th, 2020
- Genomic analysis reveals insights on virulent, emerging foodborne pathogen - UB Now: News and views for UB faculty and staff - University at Buffalo... - September 4th, 2020
- Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors - 2 Minute Medicine - September 4th, 2020
- Health history platform launches to trace genetic conditions | Digital Healthcare - Healthcare Global - Healthcare News, Magazine and Website - September 4th, 2020
- New HIV Gene Therapy, CAR-T Treatments Could be on the Horizon for Patients - BioSpace - September 4th, 2020
- Cell Suicide Gene Further Linked to Immunotherapy Response - Technology Networks - September 2nd, 2020
- Genetic mutations may be linked to infertility, early menopause - Washington University School of Medicine in St. Louis - September 2nd, 2020
- How to use precision medicine to personalise COVID-19 treatment according to the patient's genes - Down To Earth Magazine - September 2nd, 2020
- UCT professors research offers hope of treatment for sickle cell anaemia - Daily Maverick - September 2nd, 2020
- Association of recent stressful life events with mental and physical health in the context of genomic and exposomic liability for schizophrenia - 2... - September 2nd, 2020
- Finding order in the chaos of cancer mutations - Drug Target Review - September 2nd, 2020
- Mustang Bio Announces Orphan Drug Designation for MB-107 for the Treatment of X-linked Severe Combined Immunodeficiency in Newly Diagnosed Infants -... - September 2nd, 2020
- Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine - GlobeNewswire - September 2nd, 2020
- Department of Genetic Medicine | Johns Hopkins Medicine - August 10th, 2020
- Genetic Medicine | Internal Medicine | Michigan Medicine ... - August 10th, 2020
- Genetic Medicine | Department of Medicine - August 10th, 2020
- Genomics and Medicine - Genome.gov - August 10th, 2020
- New Approach to Treating Osteoarthritis Advances | NYU Langone News - NYU Langone Health - August 10th, 2020
- Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates - Business Wire - August 10th, 2020
- Here's Why Shares of Editas Medicine and Beam Therapeutics Are Soaring Today - Motley Fool - August 10th, 2020
- Grant will fund study into COVID outcome disparities in NYC - Cornell Chronicle - August 10th, 2020
- A versatile genetic control system in mammalian cells and mice responsive to clinically licensed sodium ferulate - Science Advances - August 10th, 2020
- Spark Therapeutics Deepens Drug Development Expertise in Hematology and Rare Disease with Appointment of Gallia G. Levy, MD, Ph.D., as Chief Medical... - August 10th, 2020
- Chromosomal Rearrangements Associated with Chemotherapeutic Drug Resistance | McDonnell Boehnen Hulbert & Berghoff LLP - JD Supra - August 10th, 2020
- Jae Jung, Ph.D., Appointed as Chair of Cleveland Clinic Lerner Research Institute's Department of Cancer Biology - Health Essentials from Cleveland... - August 10th, 2020
- The UK and TCELS to jointly support COVID-19 research in Thailand - GOV.UK - August 10th, 2020
- Akouos Announces Expansion of Executive Team and Board of Directors - BioSpace - August 10th, 2020
- Medical and neurobehavioural phenotypes in male and female carriers of Xp22.31 duplications in the UK Biobank. - Physician's Weekly - August 10th, 2020
- Coronavirus vaccine breakthrough: New generation cure that stops virus developed - Express - August 10th, 2020
- Global Cell and Gene Therapy Market, Forecast to 2025 by Product, Disease, End-user and Region - COVID-19 Updated - PRNewswire - August 10th, 2020
- Not Everyone Needs 8 Hours of Sleep, New Research Reveals | Time - TIME - August 10th, 2020
- Lindsey Criswell Named Director of National Institute of Arthritis and Musculoskeletal and Skin Diseases - UCSF News Services - August 10th, 2020
- Pinpointing The Cells That Keep The Bodys Master Circadian Clock Ticking - Newswise - August 10th, 2020
- Kazia Therapeutics hits A$1 on grant of Rare Pediatric Disease Designation to paxalisib for DIPG - Proactive Investors USA & Canada - August 10th, 2020
- Treatment Considerations for Prostate Cancer Progressing After Combination Therapy for mCSPC - UroToday - August 10th, 2020
- Edited Transcript of PSNL.OQ earnings conference call or presentation 6-Aug-20 9:00pm GMT - Yahoo Finance - August 10th, 2020
- Ovid and Angelini partner on treating Angelman syndrome in Europe - Pharmaceutical Technology - August 10th, 2020
- Doctoral Student/Research Assistant in Mitochondrial Biology and Signalling job with UNIVERSITY OF HELSINKI | 218596 - Times Higher Education (THE) - August 10th, 2020
- Simpler COVID-19 test could provide results in hours from saliva - University of Wisconsin-Madison - August 10th, 2020
- This company has a better version of a simpler, faster Covid-19 test - STAT - August 7th, 2020
- Mental Notes: Music Cognition Lab is dedicated to the scientific study of how music affects the brain and behavior - Vanderbilt University News - August 6th, 2020
- Nasha Fitter Elected to Board of Directors of the ACMG Foundation for Genetic and Genomic Medicine - PRNewswire - August 5th, 2020
- HDAC6 Can Control Tumor Growth and Halt Metastasis in Triple-Negative Breast Cancer - Newswise - August 5th, 2020
- Will programming a cell ever be as easy as programming an app? - SynBioBeta - August 5th, 2020
- Penn Researchers Identify New Genetic Cause of a Form of Inherited Neuropathy - Newswise - August 5th, 2020
- Genetic Variant in Persons of African Descent Linked with Stroke: Analysis - DocWire News - August 5th, 2020
- Invitae Reports $46.2 Million in Revenue Driven by More Than 120000 Samples Accessioned in the Second Quarter of 2020 - Monterey County Weekly - August 5th, 2020
- Noel R. Rose, widely regarded as the father of autoimmune disease research, dies at 92 - The Hub at Johns Hopkins - August 5th, 2020
- Atsena Therapeutics acquires exclusive rights to Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis - GlobeNewswire - August 5th, 2020
- Seragon Announces GenomeScore, the First AI Platform to Measure Rate of Aging and Physiological Changes - PRNewswire - August 5th, 2020
- Vaccine 'durability': COVID-19 immunizations coming soon but will they last? - Genetic Literacy Project - August 5th, 2020
- Aerpio Pharmaceuticals, Inc. Announces a Second Clinical Trial with Funding from MTEC to Evaluate Razuprotafib for the Prevention and Treatment of... - August 5th, 2020
- Stoke Therapeutics to Present at Upcoming Investor Conferences in August - Business Wire - August 4th, 2020
- The global cell and gene therapy market by revenue is expected to grow at a CAGR of over 30.90% during the period 20192025 - GlobeNewswire - August 4th, 2020
- Cochlear implant uses LEDs to tackle hearing loss - Optics.org - August 4th, 2020
- Rozlytrek, Roche's first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with... - August 4th, 2020
- Alnylam Pharmaceuticals : Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis -... - August 4th, 2020
- 'The younger the child, the likelier to find causative gene of infant epilepsy' - Korea Biomedical Review - Korea Biomedical Review - August 3rd, 2020
- Known genes associated with male infertility doubled - BioNews - August 3rd, 2020
- Alnylam Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis (NASH) - Business... - August 3rd, 2020
- Cancer drug is first therapy to emerge from 23andMe-GSK deal - STAT - STAT - August 3rd, 2020
- Dr. Rana on the Rationale for Video Genetic Counseling in Prostate Cancer - OncLive - August 3rd, 2020
- Metastatic Lung Cancer Study Finds That Bionano's Saphyr Outperforms NGS for the Detection of Structural Variants - GlobeNewswire - August 3rd, 2020
- Health Media in the COVID-19 Era: A mid-wave report - Features - MM&M - Medical Marketing and Media - August 3rd, 2020
- Cyberpunk 2077 shows off the ruined dreams district of Pacifica in new concept art - Critical Hit - August 2nd, 2020
- An unsupported American conspiracy theory found a foothold in Europe. New research shows how - NewsDio - August 2nd, 2020
- Study Suggests New Approach to Improve Radiation Therapy Resistance in Glioblastoma - Michigan Medicine - August 1st, 2020
- Atsena Therapeutics acquires exclusive rights to Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis - BioSpace - August 1st, 2020
- Our Genes May Explain Severity of COVID-19 and Other Infections - Quanta Magazine - August 1st, 2020
- Omega Therapeutics Lands $85M to Tap Into Control Room of Biology - Xconomy - August 1st, 2020
- EarlyBird Study: Early Detection of Adult-Onset Type 2 Diabetes in Youth - Diabetes In Control - August 1st, 2020